Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22946,94,1.07 [0.88-1.30],0.4788011949060722
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23575,176,0.96 [0.83-1.10],0.5375754754299016
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23343,1146,1.05 [0.99-1.11],0.0765356603517321
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Candidiasis,23601,405,1.03 [0.94-1.13],0.5082376844941408
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22859,2993,1.04 [1.00-1.07],0.0370005176724507
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23076,2431,1.03 [0.99-1.07],0.1879258806089532
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23361,1167,1.05 [0.99-1.11],0.0880058695762258
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23507,78,1.05 [0.85-1.30],0.6637151074464432
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22043,693,1.02 [0.95-1.09],0.621594340903725
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21292,789,1.05 [0.98-1.12],0.1783045796008164
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21340,217,1.05 [0.93-1.20],0.4398185133119295
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16525,1403,1.05 [1.00-1.10],0.0702933648754283
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21149,315,1.08 [0.97-1.20],0.1779244161603012
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23546,1352,1.03 [0.98-1.08],0.3096445580129282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Mycoses,23654,458,1.05 [0.96-1.15],0.2784651628196841
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23007,810,1.05 [0.98-1.12],0.1846119485135522
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23609,757,1.03 [0.96-1.10],0.4674249839767147
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22370,176,0.96 [0.83-1.10],0.5608800272011072
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23713,35,1.11 [0.81-1.53],0.5124054871563386
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other septicaemia,23524,672,1.02 [0.95-1.09],0.6451780347282804
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23503,74,0.94 [0.76-1.17],0.5921809567456544
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Other viral diseases,23630,165,1.17 [1.01-1.36],0.0392609166582811
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23615,150,1.14 [0.98-1.33],0.0921518139504655
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22493,296,1.06 [0.95-1.18],0.2771456359357472
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22422,225,1.03 [0.91-1.16],0.6781800262225753
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22292,98,1.17 [0.96-1.42],0.1126824041991993
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23690,35,1.18 [0.85-1.62],0.3182244439258221
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23645,140,0.98 [0.84-1.15],0.8091363612034795
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Viral warts,23547,42,1.10 [0.82-1.49],0.5092164399214221
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23576,71,0.95 [0.76-1.18],0.6173522869824235
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm,23473,204,1.06 [0.93-1.21],0.358584436979932
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23623,60,1.08 [0.85-1.38],0.5374759660385489
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23615,59,1.30 [1.01-1.68],0.0419477978393842
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23463,1049,1.01 [0.95-1.07],0.7349057427430553
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of meninges,23689,72,0.99 [0.79-1.23],0.9120267453547788
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23655,58,1.16 [0.90-1.49],0.2539542915256878
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23682,116,1.11 [0.93-1.32],0.2569852268061396
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm of ovary,23644,149,1.02 [0.88-1.19],0.8073951742992069
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Ascending colon,23693,236,0.93 [0.83-1.05],0.2404597188361543
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Caecum,23699,216,0.97 [0.86-1.10],0.6231748106969768
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23631,60,0.89 [0.70-1.12],0.317947977559065
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Descending colon,23698,131,0.85 [0.73-1.00],0.0527558135792588
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Rectum,23659,240,1.02 [0.90-1.15],0.7782385742030119
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23618,442,1.00 [0.91-1.09],0.9374487227969036
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Benign neoplasm: Transverse colon,23698,250,0.97 [0.86-1.09],0.5951321157030175
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Carcinoma in situ of breast,19191,120,0.82 [0.70-0.97],0.0188924750883643
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19262,139,0.94 [0.81-1.10],0.4595343678844871
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19255,29,0.81 [0.58-1.13],0.2216884632064999
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19282,56,1.17 [0.91-1.51],0.2255432437308679
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23652,123,0.90 [0.77-1.06],0.2117770617677401
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Haemangioma, any site",23653,121,0.91 [0.77-1.07],0.2479887597768107
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Leiomyoma of uterus,22843,501,0.96 [0.88-1.04],0.2775511927752857
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Lung cancer and mesothelioma,17005,279,0.94 [0.85-1.05],0.2839916042450172
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Lymphoid leukaemia,19258,32,0.78 [0.57-1.07],0.1182274151576468
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19379,153,1.04 [0.89-1.21],0.6244847410048526
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19322,96,1.02 [0.84-1.23],0.8388548905747023
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19390,164,0.90 [0.78-1.03],0.1289117888490582
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19288,62,1.08 [0.85-1.38],0.5207624760850516
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19289,63,1.16 [0.91-1.47],0.2343689857245222
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19274,48,0.90 [0.70-1.17],0.4391730827049844
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19352,126,1.02 [0.86-1.20],0.8484410475766744
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19318,92,1.04 [0.86-1.27],0.6893397728786994
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19297,71,1.02 [0.82-1.27],0.8615168759244125
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19260,34,1.13 [0.82-1.56],0.463850410363682
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19296,70,0.80 [0.65-0.98],0.0352895930564937
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi,23482,205,1.14 [1.00-1.30],0.0532864477625115
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanocytic naevi of trunk,23674,69,1.18 [0.94-1.49],0.1552557017242452
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Melanoma in situ,19255,75,1.13 [0.91-1.40],0.282109730377921
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19297,71,1.18 [0.94-1.48],0.1523921319809508
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19358,132,1.18 [1.00-1.40],0.050695580648363
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19432,206,0.85 [0.75-0.95],0.0060857804354598
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19307,81,1.24 [1.00-1.54],0.055366330795716
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,Other benign neoplasms of skin,23518,149,0.96 [0.83-1.12],0.6244569754998935
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20026,800,0.98 [0.92-1.05],0.5449514081052731
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20061,835,0.98 [0.92-1.05],0.6052540674536755
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23435,331,0.97 [0.88-1.07],0.5471293658684939
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21999,81,1.12 [0.91-1.38],0.2927370486444579
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23172,68,1.07 [0.85-1.34],0.5630195059668579
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22840,2550,1.06 [1.02-1.10],0.002344146750917
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22315,28,1.20 [0.84-1.73],0.3216721623994061
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23368,46,1.46 [1.09-1.97],0.0114232409705961
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23213,1295,1.04 [0.99-1.10],0.1044580813839879
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23213,1295,1.04 [0.99-1.10],0.1044580813839879
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21984,66,1.06 [0.84-1.34],0.6035965737645308
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23350,1063,1.14 [1.08-1.21],1.1097217138316444e-05
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23423,101,0.93 [0.77-1.12],0.4287230992685834
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23151,47,0.97 [0.74-1.28],0.8491064093004703
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23156,52,0.98 [0.76-1.26],0.881934699074821
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23531,209,1.01 [0.88-1.14],0.9318895977653092
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23617,54,1.29 [0.99-1.68],0.0588364738606924
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23500,178,0.86 [0.75-0.98],0.0243990041675948
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22400,113,1.25 [1.04-1.50],0.0161487088394243
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,19157,206,0.97 [0.86-1.11],0.6896706868062619
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22474,60,0.90 [0.71-1.15],0.4054999994241984
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22470,56,1.17 [0.90-1.53],0.2322650855393614
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18995,44,1.19 [0.88-1.59],0.2537487822804133
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21749,52,0.90 [0.71-1.16],0.4276428315459005
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21454,202,0.93 [0.82-1.05],0.2444146274411708
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23332,418,0.91 [0.83-0.99],0.0317703075994475
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23172,258,0.93 [0.83-1.04],0.1836844183794606
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22973,59,1.01 [0.79-1.28],0.9587143833085332
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23382,1685,1.03 [0.99-1.08],0.1448703605879225
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21013,1648,1.04 [0.99-1.09],0.0896449431886519
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18994,43,1.24 [0.92-1.67],0.1516920667922757
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",21080,100,1.01 [0.84-1.22],0.905909147976345
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,19198,247,1.09 [0.96-1.23],0.170393775089733
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18993,42,1.41 [1.03-1.92],0.0303646173170983
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21633,2682,1.06 [1.02-1.10],0.0015736677304982
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,19131,180,0.98 [0.85-1.12],0.7371693077960565
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19424,473,1.06 [0.97-1.16],0.1748811806667985
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23630,309,1.20 [1.07-1.34],0.0011206235132432
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23464,143,1.26 [1.07-1.48],0.0054662210833202
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,19037,86,0.99 [0.81-1.21],0.934595715212046
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18999,48,1.03 [0.78-1.35],0.8479447073005023
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22953,1973,1.05 [1.01-1.10],0.0188628728009029
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,19124,173,0.91 [0.80-1.05],0.2006938528999673
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,19120,169,1.12 [0.97-1.29],0.1296242612476275
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19399,448,1.04 [0.95-1.14],0.4004306987598673
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,19021,70,1.01 [0.81-1.26],0.9103239711106756
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23460,139,1.24 [1.06-1.47],0.0085991811964112
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19476,525,0.98 [0.91-1.06],0.6588651618629116
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19426,475,1.02 [0.93-1.11],0.7127039654755704
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21315,63,1.10 [0.87-1.40],0.4151681065913229
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22960,4009,1.04 [1.01-1.08],0.0035442277471433
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,21043,63,0.95 [0.75-1.20],0.6647768625785093
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,21057,77,0.98 [0.80-1.21],0.8657952067920307
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23544,1770,1.01 [0.97-1.06],0.5795250698049794
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23548,1769,1.01 [0.97-1.06],0.5780055482988402
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,21053,73,1.07 [0.86-1.33],0.5530558011214994
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23357,1372,1.05 [1.00-1.10],0.0656058498287731
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20227,1276,1.01 [0.96-1.06],0.7971343923653751
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23702,155,1.01 [0.87-1.18],0.8707401879894051
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22952,38,1.05 [0.77-1.41],0.7729391314163802
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22099,114,0.98 [0.82-1.16],0.7821660703725858
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22153,168,1.10 [0.95-1.28],0.1924662811758048
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",19169,218,1.11 [0.97-1.26],0.1219185927177571
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22135,119,1.10 [0.93-1.31],0.2806431280000896
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1479,37,0.89 [0.66-1.21],0.4549756065414957
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1570,146,1.04 [0.89-1.22],0.5900111175013458
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22039,23,1.28 [0.85-1.94],0.2326492046198725
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1464,23,0.86 [0.59-1.25],0.4268562201703817
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23305,1289,1.08 [1.02-1.14],0.0045974779929778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23203,289,0.91 [0.82-1.01],0.085683642051819
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21664,412,1.02 [0.93-1.12],0.616224969159867
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19561,610,1.05 [0.98-1.13],0.1884429927166978
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23625,206,0.87 [0.77-0.98],0.0258203935794998
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22822,45,0.93 [0.71-1.22],0.5916109101620928
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Angina pectoris,22398,739,1.06 [0.99-1.13],0.1088777928193168
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Aortic aneurysm,22857,80,0.94 [0.76-1.15],0.5224876021088523
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22807,30,1.15 [0.82-1.63],0.4198685365672943
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22913,136,0.98 [0.83-1.14],0.763316434342745
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15420,1269,0.99 [0.94-1.04],0.7504756634876468
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,AV-block,20784,213,1.07 [0.94-1.22],0.3075767099943042
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23673,260,0.85 [0.76-0.96],0.0057480709617699
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiac arrest,14255,104,1.06 [0.88-1.28],0.5319197993032829
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cardiomyopathy,20688,117,0.84 [0.71-0.99],0.0381706745270675
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20642,71,1.06 [0.85-1.33],0.5893371923225994
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23709,28,0.89 [0.64-1.24],0.4832598860361513
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Conduction disorders,21203,632,1.07 [0.99-1.15],0.0921192747955368
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22919,1271,1.03 [0.98-1.09],0.2539236021551563
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21351,6303,1.02 [1.00-1.04],0.1042308946670913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,DVT of lower extremities,22423,219,0.91 [0.81-1.03],0.1477226181513734
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Endocarditis,20618,47,1.11 [0.84-1.47],0.4532520717867898
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Heart failure, strict",23628,722,1.05 [0.98-1.13],0.1430558985594138
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertension,21885,5290,1.02 [1.00-1.05],0.0751278935727175
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, essential",21893,5298,1.02 [1.00-1.05],0.0743778863101473
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, portal",23611,37,0.73 [0.55-0.97],0.0294859746374146
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16744,149,0.98 [0.85-1.14],0.8147818593478677
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16658,63,1.01 [0.80-1.27],0.9580473841394542
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Hypotension,23597,918,0.97 [0.91-1.03],0.3396246925699132
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23063,84,1.06 [0.87-1.30],0.5625681372352076
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23097,1438,1.04 [0.99-1.10],0.0968472120908262
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23441,390,1.01 [0.92-1.11],0.8861328016324056
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Left bundle-branch block,20836,265,1.03 [0.92-1.15],0.6601571107132036
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23522,523,1.03 [0.95-1.11],0.5360214670149313
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22078,419,1.04 [0.95-1.13],0.4513266232272418
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23688,76,1.21 [0.97-1.51],0.0946729110024028
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23705,206,1.02 [0.89-1.16],0.7975334640984283
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Oesophageal varices,22239,35,0.81 [0.60-1.10],0.1764577125477749
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other aneurysm,22827,50,0.92 [0.71-1.19],0.5179373299342083
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arrhythmias,20884,313,1.05 [0.94-1.17],0.3780286008037514
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22838,61,1.25 [0.98-1.60],0.0721882671793993
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22948,171,0.98 [0.85-1.13],0.7630919963573102
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20719,148,0.96 [0.83-1.12],0.6044966479367606
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other disorders of veins,22279,75,1.03 [0.83-1.27],0.8103303897774237
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22246,42,1.15 [0.86-1.54],0.3527430989709498
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22639,31,0.82 [0.59-1.14],0.2364883381365045
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22339,135,1.03 [0.88-1.21],0.7128928140104025
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21241,670,1.00 [0.93-1.07],0.9690284484146676
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22716,37,0.89 [0.66-1.20],0.4375608885095501
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23223,446,0.95 [0.87-1.03],0.2190954612210511
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23215,280,0.93 [0.83-1.03],0.1779465271481633
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23072,464,0.97 [0.89-1.05],0.4352357786917521
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14400,249,1.00 [0.89-1.12],0.9526429491771112
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Peripheral artery disease,23010,245,0.93 [0.83-1.04],0.2214214865792644
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22488,284,0.97 [0.87-1.08],0.5755556070838554
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Pulmonary embolism,23311,376,1.03 [0.93-1.13],0.5910870545027366
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23644,490,0.96 [0.88-1.04],0.3021768311190173
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Right bundle-branch block,20757,186,1.12 [0.97-1.29],0.1179349436046152
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Secondary right heart disease,23208,273,0.93 [0.84-1.04],0.2157579442403125
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22740,132,0.91 [0.77-1.06],0.2314790421115147
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23432,453,1.01 [0.93-1.10],0.8048488626535405
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23409,494,1.00 [0.92-1.09],0.9754068763381138
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23032,62,0.99 [0.78-1.24],0.9044226500901932
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22812,35,1.22 [0.87-1.69],0.2482852434783236
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Transient ischemic attack,23235,184,1.15 [1.00-1.32],0.0552443448564488
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23174,175,1.06 [0.92-1.22],0.4501590413775765
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Varicose veins,22582,378,1.03 [0.94-1.14],0.5287053804394151
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22786,82,0.87 [0.72-1.06],0.1758926515199085
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter IX Diseases of the circulatory system,Venous thromboembolism,23528,597,1.01 [0.94-1.09],0.787528970535182
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23677,196,1.03 [0.90-1.18],0.6652983680275097
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21072,1600,1.04 [0.99-1.09],0.0955252278263108
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Any mental disorder,23198,3726,1.02 [0.99-1.06],0.1250752696380414
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23652,232,0.98 [0.87-1.11],0.7980699128736168
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21172,1700,1.04 [0.99-1.09],0.1108289078577407
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19548,76,0.98 [0.79-1.21],0.8338965740410872
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Smoking dependency,23359,1035,1.03 [0.97-1.09],0.3413217126610502
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20675,1203,1.02 [0.97-1.08],0.4673445007693386
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter V Mental and behavioural disorders,Vascular dementia,23293,94,0.96 [0.80-1.17],0.7043183553763103
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Alzheimer disease,23711,321,0.93 [0.84-1.03],0.191285914601848
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16233,51,0.91 [0.70-1.18],0.4682692229526395
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Bell's palsy,21852,70,0.98 [0.78-1.22],0.8260294419025045
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22337,555,1.03 [0.95-1.11],0.4940645444386643
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral cysts,23362,184,1.01 [0.88-1.16],0.924364294505485
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23648,238,0.92 [0.82-1.03],0.156166427091712
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23290,38,0.90 [0.67-1.21],0.5034420890522626
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23700,43,1.25 [0.93-1.68],0.1372594234184661
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23222,44,0.87 [0.66-1.14],0.3227872631612088
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Epilepsy,22447,241,0.93 [0.83-1.05],0.2370669780290732
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23349,1143,1.02 [0.96-1.07],0.5562627150211871
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23667,298,1.02 [0.91-1.13],0.7822467203296981
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Falls/tendency to fall,23182,2487,0.95 [0.92-0.99],0.0066210523110768
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Generalized epilepsy,23400,41,1.23 [0.91-1.67],0.1702883625573201
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hemiplegia,23598,188,0.96 [0.84-1.09],0.5269672523316318
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Hydrocephalus,23232,54,1.04 [0.80-1.33],0.7842251346748261
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23695,63,1.08 [0.85-1.36],0.5413975276555393
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21892,110,0.86 [0.72-1.02],0.0741281145250324
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21835,53,1.16 [0.89-1.51],0.2649234486917718
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Memory loss,23180,95,1.07 [0.88-1.30],0.4766577840588371
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Migraine,22644,438,1.06 [0.97-1.16],0.2159708039010621
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23611,396,1.05 [0.95-1.15],0.3390133838618273
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Motor neuron disease,16323,116,1.02 [0.85-1.21],0.8602096232682345
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23523,127,1.06 [0.90-1.25],0.5036540531225078
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22992,1210,1.02 [0.97-1.08],0.4044457262516878
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Neurological diseases,22321,3205,1.00 [0.97-1.04],0.8272028812160088
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23377,125,0.95 [0.80-1.11],0.501127043403383
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22152,370,1.03 [0.94-1.14],0.4962677131612183
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23661,197,1.00 [0.88-1.14],0.9756038117728428
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19181,579,0.96 [0.89-1.03],0.2426751962067602
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23237,59,1.08 [0.84-1.37],0.5571480011809233
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other disorders of nervous system,23289,111,0.89 [0.75-1.06],0.1848086910050516
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23507,138,1.04 [0.88-1.22],0.6542814262201642
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other facial nerve disorders,21860,78,0.98 [0.80-1.21],0.8682114205672125
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other headache syndromes,22274,68,1.10 [0.87-1.38],0.428319712746444
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other neurological diseases,23612,434,1.02 [0.93-1.11],0.7029022335966546
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Other sleep disorders,22551,345,0.96 [0.87-1.06],0.425638380320291
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Parkinson's disease,23688,140,0.97 [0.83-1.14],0.7256092400890447
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23250,72,1.15 [0.91-1.44],0.2419103815574879
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Restless leg syndrome,23710,72,0.97 [0.78-1.21],0.8057579745451933
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Sleep apnoea,23558,278,0.96 [0.86-1.07],0.4306748306815304
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Small fibre neuropathy,23498,34,1.16 [0.84-1.61],0.3667298198844262
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23702,141,0.95 [0.81-1.10],0.4716492815662959
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21840,58,1.02 [0.80-1.31],0.8442303702112497
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23711,324,0.94 [0.85-1.04],0.2034497497008709
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23253,91,0.96 [0.79-1.17],0.6995887714827254
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23204,91,0.99 [0.81-1.20],0.8886763973901717
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23313,419,0.93 [0.85-1.02],0.1259573179553289
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23591,140,1.03 [0.88-1.20],0.7290673414506779
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22745,53,1.03 [0.80-1.33],0.8179976103161394
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22736,44,1.21 [0.90-1.62],0.2096800694496403
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23602,58,1.19 [0.92-1.53],0.1791700791054373
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23458,144,0.90 [0.77-1.05],0.1813756083446664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1471,29,0.96 [0.68-1.36],0.8293901957950331
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1753,56,0.86 [0.67-1.10],0.2177276071358765
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23197,84,0.86 [0.70-1.04],0.122455823425509
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23560,904,1.04 [0.98-1.11],0.2286570566997945
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23341,649,0.97 [0.90-1.04],0.3447928348933713
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22954,262,0.96 [0.85-1.07],0.4551178586313303
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23637,743,0.95 [0.89-1.02],0.1289014210928187
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23701,62,1.02 [0.81-1.30],0.839547139724102
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23568,674,0.95 [0.88-1.01],0.1214343036172751
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23673,359,0.95 [0.86-1.05],0.3025670128752815
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23627,183,0.89 [0.78-1.02],0.1012474472408885
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22730,38,1.12 [0.82-1.54],0.4681294502277138
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22732,40,1.39 [1.01-1.90],0.0408968205815599
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22753,61,1.02 [0.80-1.29],0.8998635909853567
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23633,620,0.98 [0.91-1.06],0.6266622050320207
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23163,150,0.92 [0.79-1.07],0.2582063683485508
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22950,56,0.95 [0.74-1.21],0.6575353393080499
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23405,91,0.98 [0.80-1.19],0.8196260248230407
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23591,277,0.94 [0.84-1.05],0.2889950918377331
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23076,182,0.94 [0.82-1.07],0.3559538986368344
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23564,120,0.87 [0.74-1.02],0.0949541448878218
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23419,406,0.98 [0.90-1.08],0.7451839514762053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23248,135,0.97 [0.83-1.13],0.6793572134957633
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22162,2207,1.02 [0.98-1.07],0.2425533438940439
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23556,242,0.94 [0.84-1.06],0.3067500055178961
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23691,139,0.98 [0.84-1.15],0.8201380762833513
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23030,338,0.99 [0.90-1.10],0.894917056282398
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23373,59,0.96 [0.75-1.22],0.7163497199362794
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23687,48,1.08 [0.82-1.42],0.5858364761225291
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22775,83,0.88 [0.72-1.08],0.2146106745847387
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22822,130,0.89 [0.76-1.04],0.1484484639908293
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22749,93,1.12 [0.92-1.36],0.2526704774062029
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22953,59,0.93 [0.73-1.18],0.5276411177240999
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22713,57,0.94 [0.74-1.20],0.6429337610585112
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23117,104,0.98 [0.82-1.17],0.8193948505013879
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23167,154,0.93 [0.81-1.08],0.3633369592136063
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22804,112,1.06 [0.89-1.27],0.5187472466147534
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22738,82,1.23 [0.99-1.52],0.0613806623693802
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22715,59,1.08 [0.84-1.38],0.5598118919189847
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21757,1802,0.98 [0.94-1.02],0.3417411702935032
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22770,78,1.05 [0.85-1.30],0.6533989017012769
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23488,375,0.98 [0.89-1.08],0.7413966690160867
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23153,40,1.00 [0.75-1.34],0.9996594040578546
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23256,143,1.06 [0.91-1.25],0.4359409891216778
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23489,100,0.87 [0.73-1.05],0.1399359220137327
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23670,92,0.92 [0.77-1.12],0.4139597884844088
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23603,124,0.97 [0.82-1.14],0.6779739760400111
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23453,64,1.03 [0.81-1.29],0.831834231210421
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23453,64,1.10 [0.87-1.40],0.4389016552913111
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23620,700,0.99 [0.92-1.06],0.7646232302915479
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23399,479,1.03 [0.94-1.12],0.5544252838602606
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23023,103,0.92 [0.77-1.09],0.3287576869716523
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22996,76,1.09 [0.88-1.35],0.4418325356610316
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute pharyngitis,23470,72,0.85 [0.69-1.05],0.1278633941165429
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23600,202,0.93 [0.81-1.05],0.2436284005273006
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23451,53,1.01 [0.79-1.31],0.9126425060760626
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,All influenza,22228,114,0.99 [0.83-1.18],0.94239699051153
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22227,113,1.00 [0.84-1.19],0.9740430216941433
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Allergic asthma (mode),16840,114,1.14 [0.95-1.36],0.1534958151491445
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Allergic rhinitis,23593,246,1.14 [1.01-1.29],0.031042313011326
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18383,1817,1.04 [1.00-1.09],0.0774040554513656
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18519,1793,1.04 [0.99-1.09],0.0913963259283035
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23354,116,1.07 [0.90-1.27],0.4676847686812309
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22177,63,1.14 [0.90-1.46],0.2786805455835338
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Bronchiectasis,20464,345,1.18 [1.06-1.30],0.0019622291282203
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20180,61,1.14 [0.89-1.46],0.2898581026896027
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22709,2590,1.04 [1.00-1.08],0.0341215862083526
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22606,57,0.93 [0.73-1.18],0.5408429957732861
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Chronic sinusitis,22676,127,1.13 [0.96-1.34],0.1474893500319573
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23560,901,1.01 [0.95-1.08],0.6730709692036188
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Deviated nasal septum,22612,63,1.06 [0.84-1.35],0.6140885739465607
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21891,4455,1.05 [1.02-1.08],0.0009254921247196
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22838,289,1.02 [0.91-1.13],0.7842847064417124
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Early onset COPD,22941,282,1.04 [0.93-1.16],0.5428016732907157
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Emphysema,20350,231,1.18 [1.04-1.34],0.0095355585636986
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22259,204,1.03 [0.91-1.17],0.647485169346657
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Influenza and pneumonia,23534,1420,1.02 [0.97-1.07],0.4844300161402876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Interstitial lung disease,22294,239,1.03 [0.92-1.16],0.6054989114506772
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Later onset COPD,22904,619,1.01 [0.93-1.08],0.8791841398876759
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23706,185,0.97 [0.84-1.11],0.6231346167900906
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Nasal polyp,22610,61,1.11 [0.87-1.41],0.4148312140193915
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23508,813,1.03 [0.97-1.10],0.3393458553505827
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of pleura,23546,1514,1.03 [0.98-1.08],0.1890200339430808
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23229,680,1.09 [1.02-1.17],0.0165780594685129
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other pleural conditions,22067,35,0.79 [0.59-1.07],0.1250838957313759
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23634,301,1.00 [0.90-1.11],0.9439640955421664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23634,1029,1.06 [1.00-1.12],0.0529700573078599
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural effusion,22752,720,1.02 [0.96-1.10],0.497627211146004
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pleural plaque,22073,41,1.10 [0.82-1.47],0.5457217895291973
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23320,1206,1.01 [0.96-1.07],0.7205932125139212
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23678,157,0.94 [0.81-1.08],0.3731330088462123
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pneumothorax,22120,88,0.99 [0.81-1.20],0.8934994521051913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pollen allergy,23690,208,1.12 [0.98-1.28],0.0863241663050742
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Pulmonary oedema,23385,52,0.82 [0.65-1.05],0.1219686690233992
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Respiratory insufficiency,16767,41,1.25 [0.92-1.70],0.1485202674884577
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23489,794,1.03 [0.96-1.10],0.4390570561716185
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22795,246,1.15 [1.02-1.30],0.0276850591073674
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Viral pneumonia,22299,185,1.00 [0.87-1.15],0.9862362219145758
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23362,145,0.99 [0.85-1.15],0.8834626155809533
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11409,91,1.02 [0.83-1.24],0.8765840773200338
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16949,34,1.02 [0.73-1.41],0.9256981793102044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute appendicitis,23544,122,0.80 [0.69-0.94],0.0070822870883919
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute gastritis,17804,71,0.99 [0.79-1.23],0.9029122341060518
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute pancreatitis,21743,141,1.20 [1.02-1.41],0.0280319679548008
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Acute peritonitis,23213,73,1.14 [0.92-1.43],0.2320755131905867
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Alcoholic liver disease,22968,33,1.01 [0.73-1.39],0.9657632606325188
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Barrett oesophagus,18033,300,1.13 [1.01-1.26],0.0350101535755879
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21672,70,1.31 [1.04-1.66],0.0238475611491884
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23344,70,1.31 [1.03-1.65],0.025176928396901
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholecystitis,21757,155,1.05 [0.90-1.21],0.5497078533065898
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Cholelithiasis,22626,1024,1.02 [0.96-1.08],0.6118527241861769
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic gastritis,18023,290,1.11 [0.99-1.25],0.0624744145197757
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Chronic pancreatitis,21639,37,0.91 [0.68-1.23],0.5474244155731093
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23641,67,0.86 [0.69-1.07],0.1796831074441381
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Coeliac disease,22385,127,1.06 [0.90-1.25],0.4809162908361265
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Collagenous colitis,22060,95,0.99 [0.82-1.20],0.9021799325896832
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23588,138,1.03 [0.88-1.20],0.7458546050647437
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Constipation,23422,1461,1.01 [0.96-1.06],0.6512655988339613
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn disease,22041,76,1.04 [0.84-1.29],0.7277733793007901
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23398,53,0.99 [0.77-1.28],0.9595756291304156
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Crohn's disease NAS,22042,77,0.99 [0.80-1.23],0.93683649373782
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Dental caries,22993,196,0.98 [0.86-1.12],0.7996215743519912
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22281,2104,1.01 [0.97-1.05],0.6979589372401337
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of appendix,23580,158,0.90 [0.78-1.04],0.1452984725501044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of liver,23624,689,1.06 [0.99-1.14],0.1048040216595037
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21719,3986,1.00 [0.98-1.03],0.7548839280056767
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23307,510,1.00 [0.92-1.09],0.948753522408881
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of peritoneum,23609,469,1.08 [0.99-1.17],0.0984509651798351
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22902,105,0.94 [0.79-1.13],0.5325690004274206
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of salivary glands,22771,57,1.01 [0.78-1.29],0.9606320908710584
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of the digestive system,23459,1201,1.01 [0.95-1.06],0.8494461308666599
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diseases of tongue,22772,90,1.02 [0.84-1.24],0.8638950729297931
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22969,1367,1.04 [0.98-1.09],0.1712581637062969
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19682,2767,1.02 [0.99-1.06],0.2297330527368927
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Duodenal ulcer,17850,117,1.08 [0.91-1.29],0.3808916765141125
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23662,97,1.05 [0.86-1.27],0.652431680514489
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23628,56,1.21 [0.94-1.56],0.1418955715821951
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23020,85,0.94 [0.77-1.14],0.5142369621653116
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17015,100,1.10 [0.91-1.33],0.3066359228397019
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Functional dyspepsia,18318,585,1.06 [0.98-1.14],0.1617861573848614
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastric ulcer,18032,299,0.93 [0.84-1.04],0.2031337349531026
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20140,2407,1.00 [0.97-1.04],0.8740082402446061
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18146,413,0.97 [0.88-1.06],0.4642042011964282
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18535,7247,1.01 [0.99-1.04],0.1924149492779537
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,GI-bleeding,23216,958,0.99 [0.93-1.05],0.6411199507677838
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22856,59,1.08 [0.84-1.39],0.5491901145132221
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17764,1095,1.07 [1.01-1.14],0.0140922081145857
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22968,33,0.74 [0.54-0.99],0.0461886633391426
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Hernia,22666,2489,1.00 [0.97-1.04],0.8810700297484355
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impacted teeth,23636,51,1.34 [1.02-1.76],0.0378237047434085
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Impaction of intestines,16973,58,1.13 [0.88-1.46],0.332393245949416
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Inguinal hernia,20325,148,0.94 [0.80-1.09],0.3893134701336542
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16999,84,0.92 [0.75-1.12],0.4011585625254394
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Intestinal malabsorption,22412,154,1.08 [0.93-1.26],0.2956498772092485
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17614,699,1.06 [0.99-1.14],0.1066900607400884
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23699,302,1.22 [1.09-1.36],0.0005497922621776
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22674,709,1.11 [1.04-1.19],0.0032629681503625
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22918,953,1.11 [1.04-1.18],0.0010227619964582
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophageal obstruction,17865,132,1.14 [0.96-1.34],0.1346033918088174
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oesophagitis,18229,496,1.02 [0.94-1.11],0.6156725944076511
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23670,135,1.00 [0.85-1.18],0.9785013109511664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20231,54,1.10 [0.85-1.43],0.4510642711931975
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18005,1090,1.01 [0.96-1.07],0.6497382239732263
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21853,251,1.03 [0.92-1.16],0.6182647156724537
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21765,163,0.98 [0.85-1.13],0.7973792904359956
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestine,18296,1381,1.01 [0.96-1.06],0.8059403936149475
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of intestines,21828,4913,1.01 [0.98-1.04],0.4686572044546697
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22772,198,0.99 [0.87-1.13],0.8892232084483159
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of liver,23506,571,1.08 [1.00-1.17],0.0494320983587446
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18251,518,1.04 [0.96-1.13],0.3017988345764103
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of pancreas,21735,133,0.95 [0.80-1.11],0.4931875524316571
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23553,413,1.06 [0.96-1.16],0.2539538081043549
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18664,931,1.01 [0.95-1.07],0.8235138216619861
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23233,975,0.99 [0.93-1.05],0.7199245666755474
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22951,154,0.95 [0.82-1.10],0.5191266500073768
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18427,1512,1.02 [0.97-1.07],0.5116185875740875
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19538,1805,0.97 [0.93-1.02],0.2386486617118162
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23026,91,0.96 [0.79-1.17],0.6872418475050162
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22804,839,1.10 [1.03-1.17],0.0061561425425331
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17202,287,1.00 [0.89-1.11],0.9805731237749866
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23619,65,1.19 [0.94-1.51],0.1441574848065302
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17343,428,0.96 [0.88-1.05],0.353024398485797
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22377,119,1.03 [0.86-1.22],0.7753296501076425
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Recurring oral aphthae,23703,62,0.87 [0.69-1.09],0.2311270364341521
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22797,110,0.93 [0.78-1.10],0.4028918628393804
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Toxic colitis,22020,55,1.07 [0.83-1.38],0.6019148080599315
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17943,210,1.11 [0.97-1.26],0.1235500003325003
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ulcerative colitis,22114,149,1.18 [1.01-1.39],0.0350173923010334
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22091,126,1.17 [0.99-1.38],0.0740808519776337
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Umbilical hernia,20331,154,0.88 [0.76-1.01],0.074862966419829
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,17079,164,0.95 [0.82-1.09],0.458918520293642
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Ventral hernia,20396,219,1.02 [0.90-1.16],0.7032958018227415
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XI Diseases of the digestive system,Volvulus,16990,75,0.89 [0.72-1.09],0.2675014854536328
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23637,214,1.11 [0.98-1.27],0.1104758152045201
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23435,75,0.85 [0.69-1.04],0.1205426692252511
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21924,193,1.05 [0.92-1.21],0.435970651821683
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23239,546,1.00 [0.92-1.08],0.9051023236652564
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22821,128,1.10 [0.93-1.30],0.2761629110728005
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22008,277,0.94 [0.84-1.05],0.2673761487980269
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23434,239,1.07 [0.95-1.20],0.2951547808576694
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23610,415,1.00 [0.91-1.10],0.969180501200028
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23240,45,0.91 [0.70-1.19],0.5002787645786175
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22328,2741,1.01 [0.97-1.04],0.6573163059005545
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23327,402,0.93 [0.85-1.02],0.1251970340019454
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23200,275,0.98 [0.88-1.10],0.7863944909220489
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23429,736,0.99 [0.93-1.06],0.8492594418670041
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23693,66,1.03 [0.82-1.30],0.7916876478073137
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21816,85,0.86 [0.70-1.04],0.119203558316576
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22964,39,1.03 [0.76-1.38],0.860440072146808
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23420,225,1.07 [0.94-1.21],0.3123948216596333
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22098,367,1.12 [1.01-1.24],0.0284580932230102
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21779,48,1.10 [0.84-1.45],0.4776129406530198
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23620,67,0.82 [0.66-1.01],0.0631936518197726
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22829,136,1.07 [0.91-1.26],0.4130512883217504
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23509,149,0.76 [0.66-0.88],0.0002067226614935
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23236,41,1.00 [0.74-1.33],0.9779931396171528
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21787,56,0.98 [0.77-1.25],0.8573017231487245
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23121,1390,1.03 [0.98-1.08],0.2293900658860976
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22128,397,1.12 [1.02-1.23],0.0188078576158468
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21783,52,1.09 [0.84-1.41],0.5191476177039038
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23638,278,0.86 [0.78-0.96],0.0080626436996777
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23270,75,0.84 [0.69-1.04],0.1081591090330037
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23575,215,0.83 [0.73-0.93],0.001901780624653
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23664,241,1.09 [0.97-1.24],0.1570404341816117
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21870,139,1.07 [0.92-1.26],0.3727182982709245
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21959,228,1.06 [0.93-1.19],0.3974217890514395
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23653,230,1.09 [0.96-1.23],0.1988202115458165
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21909,178,1.02 [0.89-1.18],0.7366503760502431
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23679,126,0.90 [0.77-1.06],0.2124877921365305
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20235,114,1.04 [0.88-1.24],0.6376753734825389
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21522,5518,0.99 [0.96-1.01],0.3804645755363842
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20315,4311,0.99 [0.97-1.02],0.6578021995638321
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20188,67,1.02 [0.82-1.28],0.8402366963653645
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20332,137,1.04 [0.89-1.22],0.6363644944852862
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20376,181,1.02 [0.89-1.18],0.7357663623949802
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23464,103,0.82 [0.69-0.98],0.0293736823061002
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20298,103,0.97 [0.81-1.17],0.7582746019534237
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17202,1198,0.97 [0.92-1.03],0.3070196146260423
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23579,200,1.00 [0.87-1.13],0.9541103665412
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20696,501,1.02 [0.94-1.11],0.6389670302274044
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19909,7025,1.00 [0.98-1.03],0.7941775330752636
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21226,115,1.00 [0.85-1.19],0.957046149882195
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20239,118,1.09 [0.92-1.29],0.3412442756830053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20722,601,1.02 [0.95-1.10],0.617542744353748
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22816,2621,1.02 [0.98-1.06],0.2643622704284913
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20276,155,1.01 [0.87-1.17],0.902193777584384
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20458,337,1.12 [1.01-1.24],0.0287110432303953
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20273,152,1.15 [0.98-1.34],0.0814046481995302
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22849,90,0.90 [0.74-1.09],0.2834917569134223
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17628,1624,1.00 [0.95-1.05],0.985555987691388
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16183,179,1.06 [0.92-1.21],0.4360765904021665
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23698,176,1.03 [0.89-1.19],0.6879472239498433
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16096,92,1.01 [0.84-1.23],0.8933063092917353
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16508,504,0.90 [0.83-0.98],0.010794312699939
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20412,291,0.94 [0.85-1.05],0.2795477726949664
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16552,548,1.00 [0.92-1.08],0.9242346262093208
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20253,58,1.17 [0.91-1.51],0.2288528272856841
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20814,619,1.07 [0.99-1.16],0.0781072211104623
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20486,291,1.02 [0.92-1.14],0.7030150370571568
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16514,510,1.00 [0.92-1.09],0.9433662797026116
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20193,72,1.25 [1.00-1.57],0.0535460104423251
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20183,62,1.01 [0.80-1.28],0.9242530202851742
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,21156,45,1.13 [0.85-1.51],0.3857308383281272
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23298,2187,0.98 [0.94-1.02],0.3832604009929193
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22680,1569,0.98 [0.93-1.03],0.3769776840238548
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23528,518,1.05 [0.96-1.13],0.2918618681075021
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18632,2628,1.00 [0.96-1.03],0.8072436787009447
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,16063,59,0.99 [0.78-1.26],0.945560566643994
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20210,89,1.15 [0.94-1.41],0.1658229206703013
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,16046,42,0.88 [0.66-1.16],0.351049723369974
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16181,177,1.02 [0.89-1.17],0.8083122923113271
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21372,261,0.92 [0.82-1.03],0.1383221273711836
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21607,496,0.97 [0.89-1.05],0.4386259148003737
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23689,97,1.11 [0.91-1.34],0.3062207192060691
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21962,1767,1.04 [0.99-1.09],0.0840348601459853
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20235,114,0.87 [0.73-1.03],0.0991330607937902
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16209,205,0.91 [0.80-1.03],0.1451917262499731
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20895,700,1.01 [0.94-1.08],0.8750771820281092
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18216,2212,0.98 [0.94-1.02],0.3401679734356202
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22871,112,0.90 [0.76-1.07],0.2190714704785159
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23693,73,0.89 [0.72-1.10],0.2691671202574632
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20189,68,1.13 [0.90-1.43],0.2891095570341581
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21400,1279,1.03 [0.98-1.09],0.1996338231334568
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20192,71,1.14 [0.91-1.42],0.2617899829318661
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17730,1726,1.05 [1.00-1.09],0.054691605280107
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21239,128,0.98 [0.83-1.15],0.7927523118930396
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20170,49,0.98 [0.75-1.28],0.8740909287698558
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20368,173,0.95 [0.83-1.10],0.4953128350455035
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20620,499,1.00 [0.92-1.08],0.9652529938580028
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23205,446,1.12 [1.03-1.23],0.0100956184943016
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20753,558,1.00 [0.93-1.08],0.9636126419890024
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23540,501,1.06 [0.97-1.15],0.1954934770273814
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23686,57,1.27 [0.98-1.64],0.0674556142370357
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20315,194,0.96 [0.85-1.10],0.5803294288890415
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18179,795,1.02 [0.96-1.09],0.5460919873058321
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20697,576,1.00 [0.93-1.08],0.994860549650724
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20227,106,1.10 [0.92-1.33],0.2827753477520277
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",16078,74,0.92 [0.74-1.13],0.4081274006568894
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18302,2298,1.04 [1.00-1.08],0.0691949769508446
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16734,730,0.99 [0.93-1.06],0.8161785320619113
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23011,252,1.14 [1.01-1.29],0.0307541069192947
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23662,70,0.98 [0.79-1.22],0.841896410752457
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21729,48,1.19 [0.90-1.56],0.2267608908425789
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,16078,74,0.88 [0.71-1.08],0.2111227499250694
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20292,97,1.09 [0.90-1.32],0.3965215551101255
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16525,521,1.05 [0.96-1.13],0.2888656581065754
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20404,283,0.88 [0.79-0.97],0.0143643159499584
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20442,247,1.13 [1.01-1.28],0.0412727231659235
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20431,236,1.00 [0.88-1.13],0.9908943664118638
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18287,78,1.17 [0.94-1.46],0.1525670782685471
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23692,63,1.11 [0.88-1.41],0.3713209740510053
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20673,552,0.97 [0.90-1.05],0.4364474833870938
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22909,150,1.10 [0.94-1.28],0.2332523870176579
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22569,2448,1.02 [0.98-1.06],0.3103803647755027
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20257,136,0.86 [0.74-1.01],0.0609163247599827
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20676,481,1.05 [0.97-1.15],0.2423865822061658
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22184,224,0.96 [0.85-1.09],0.5141420663733756
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20408,213,1.03 [0.91-1.17],0.660360082226099
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21704,1509,0.99 [0.94-1.03],0.537661631440615
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21220,1025,0.97 [0.92-1.03],0.3904645417665173
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20177,56,1.06 [0.82-1.36],0.6703537329316309
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22972,213,1.02 [0.90-1.16],0.7113167891608256
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20296,175,1.00 [0.87-1.15],0.9776164674535284
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20235,114,0.89 [0.75-1.05],0.1702484561686592
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),16049,45,1.22 [0.92-1.62],0.1762721920742777
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Acute renal failure,22868,1031,1.03 [0.98-1.10],0.2657439177441852
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17745,86,1.14 [0.93-1.40],0.2133776396433336
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23115,100,0.98 [0.81-1.17],0.7879956543679631
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23573,198,1.07 [0.94-1.23],0.2930654268607455
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23397,22,0.76 [0.52-1.09],0.1360365431222884
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22992,1155,1.01 [0.95-1.06],0.8014623840523711
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23571,58,0.91 [0.72-1.16],0.4377478820179812
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23539,205,1.00 [0.88-1.14],0.9462172448353152
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Cystitis,20951,220,0.98 [0.86-1.10],0.7003639907890558
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Dialysis,21881,44,1.47 [1.09-1.99],0.0122016980615199
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Disorders of breast,23297,282,0.98 [0.88-1.10],0.7811939992099121
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Endometriosis,17808,149,1.05 [0.90-1.22],0.5629702457858715
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17994,335,0.88 [0.80-0.98],0.0149032577000465
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18515,856,1.03 [0.97-1.10],0.3479578740473336
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18416,4267,1.01 [0.98-1.04],0.5096432346094437
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23565,52,1.00 [0.78-1.29],0.999165860552534
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21720,180,0.95 [0.83-1.09],0.4569259351702943
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23229,344,0.95 [0.86-1.05],0.2905001132306782
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Irregular menses,23311,107,0.76 [0.64-0.90],0.0013849989288739
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Menorrhagia,17921,262,0.97 [0.87-1.09],0.6624246514174488
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20796,65,1.09 [0.86-1.38],0.4869573993938149
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19753,2094,1.00 [0.96-1.04],0.93740147898964
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17780,121,1.04 [0.87-1.23],0.6819383768464531
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23702,57,1.26 [0.97-1.64],0.0788510998848384
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23702,71,0.93 [0.75-1.15],0.503212465551937
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22622,1891,1.01 [0.97-1.05],0.6284807914729366
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21141,410,0.99 [0.91-1.09],0.8838685515007303
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23114,99,1.00 [0.83-1.21],0.9802219497752992
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23660,326,1.08 [0.97-1.19],0.173162884569717
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23657,77,1.03 [0.83-1.27],0.7900462949059373
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22352,1621,1.01 [0.97-1.06],0.5865608516436466
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23064,179,1.02 [0.89-1.17],0.7876295862281963
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17792,133,1.20 [1.02-1.42],0.0316466750874693
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17994,335,1.02 [0.92-1.13],0.7227607585400542
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17762,103,1.02 [0.85-1.23],0.8029067494487512
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17841,182,1.04 [0.91-1.20],0.574707054573464
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21766,226,0.99 [0.88-1.12],0.894747523977775
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23440,106,1.19 [0.99-1.44],0.0629350155088743
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17911,252,1.06 [0.94-1.19],0.3357349603454441
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17749,90,0.92 [0.76-1.12],0.4057266306613876
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18206,547,1.00 [0.92-1.08],0.9815141056929428
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17798,139,1.06 [0.91-1.25],0.4441947001246384
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18164,505,1.01 [0.93-1.10],0.7776481637262764
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23546,33,1.10 [0.80-1.53],0.5531532667260937
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23555,2015,1.01 [0.97-1.05],0.6389986824154186
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21684,144,1.07 [0.91-1.25],0.4059270642548689
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21922,85,1.03 [0.84-1.26],0.7621660278541298
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23406,31,0.89 [0.64-1.23],0.4785492245605358
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urethral stricture,20855,124,1.14 [0.96-1.35],0.1315994267550048
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Urolithiasis,23604,229,1.05 [0.93-1.19],0.4570760680415464
PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",Chapter XIV Diseases of the genitourinary system,Uterine polyps,17778,119,1.13 [0.95-1.34],0.1827984994444573
